April 21 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd 600196.SS:
SAYS UNIT PLANS TO BUY AROUND 3.87% STAKE IN SHANGHAI HENLIUS BIOTECH INC FOR HK$ 517.4 MILLION ($66.67 million)
Source text
Further company coverage: 600196.SS
($1 = 7.7608 Hong Kong dollars)
(Reporting by Beijing Newsroom)
((yukun.zhang@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.